Insulet Corporation
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Insulet Corporation sits in the top decile of US sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count).
Insulet Corporation: 16 sponsored US clinical trials, 3 recruiting.
Insulet Corporation sponsors 16 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 12 completed. The most-studied condition in this pipeline is Type 1 Diabetes, with 2 trials.
Top-decile sponsor footprint
Insulet Corporation ranks in the top decile of sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
12 of 12 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
16 total, page 1 of 1
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
NCT07579702
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
NCT07521475
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
NCT06144554
An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes
NCT07276776
Simplified Onboarding in Adults With Type 2 Diabetes
NCT07070830
Omnipod® SmartAdjust 2.0 System Compared to the Omnipod® 5 System in Individuals With Type 1 or Type 2 Diabetes
NCT06865989
OP5-005 Using Omnipod 5 in Adults With Type 2
NCT05815342
Omnipod 5 System Compared to Pump Therapy
NCT05409131
Omnipod® 5 Automated Insulin Delivery System in Patients With Type 2 Diabetes
NCT04617795
Omnipod Horizon™ Automated Glucose Control System Preschool Cohort
NCT04476472
Continuous Glucose Monitoring System (CGM)-Informed Bolus Calculator Study
NCT04320069
Pivotal Omnipod Horizon™ Automated Glucose Control System
NCT04196140
Prepivotal Omnipod Horizon™ Automated Glucose Control System
NCT04176731
Insulet Artificial Pancreas Free-Living IDE3
NCT03216460
Insulet Artificial Pancreas Evaluating Meal Performance and Moderate Exercise (IDE2)
NCT03064906
Insulet Artificial Pancreas Early Feasibility Study
NCT02897557
Therapeutic Areas
What is open in the Insulet Corporation pipeline
3 recruiting of 16 indexed (19% open); 12 completed (75%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Type 1 Diabetes (2 trials), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Insulet Corporation: open-pipeline peers nationwide
Peers matched on 16 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
Insulet Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 16 trials (± recruiting share)
- Accelerated Community Oncology Research Network · 16 trials · 0% recruiting
- Altimmune · 16 trials · 6% recruiting
- American University · 16 trials · 13% recruiting
- Anthera Pharmaceuticals · 16 trials · 0% recruiting
Sponsors near 19% open enrollment (± trial volume)
- EyePoint Pharmaceuticals · 19% recruiting · 16 trials
- Hebrew SeniorLife · 19% recruiting · 32 trials
- University of California, Davis · 19% recruiting · 657 trials
- Medical University of South Carolina · 19% recruiting · 755 trials
Related
What to do with this Insulet Corporation page
16 registered trials is a research-attention snapshot, not an endorsement of Insulet Corporation or any single study.
- 3 of Insulet Corporation's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 1 Diabetes is the condition Insulet Corporation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 1 Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Insulet Corporation pipeline card: 16 registered trials from official public datasets.Report a data error.